tiprankstipranks
Santhera Pharmaceuticals Holding (CH:SANN)
:SANN
Switzerland Market
SANN
Santhera Pharmaceuticals Holding
RESEARCH TOOLSreports
Want to see CH:SANN full AI Analyst Report?

Santhera Pharmaceuticals Holding (SANN) Ratios

4 Followers

Santhera Pharmaceuticals Holding Ratios

CH:SANN's free cash flow for Q4 2025 was CHF―. For the 2025 fiscal year, CH:SANN's free cash flow was decreased by CHF and operating cash flow was CHF―. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Dec 23Mar 23
Liquidity Ratios
Current Ratio
 1.29- 1.64 0.78 0.06
Quick Ratio
 0.89- 1.26 0.74 0.06
Cash Ratio
 0.36- 0.89 0.69 0.03
Solvency Ratio
 -0.27- -0.29 1.16 -0.63
Operating Cash Flow Ratio
 -0.56- -0.77 1.07 -0.60
Short-Term Operating Cash Flow Coverage
 -1.46- -5.11 2.26 -1.35
Net Current Asset Value
CHF -74.53MCHF -79.66MCHF -48.98MCHF -15.03MCHF -104.35M
Leverage Ratios
Debt-to-Assets Ratio
 0.66- 0.27 0.21 0.70
Debt-to-Equity Ratio
 -8.27- 1.49 0.38 -1.02
Debt-to-Capital Ratio
 1.14- 0.60 0.28 59.17
Long-Term Debt-to-Capital Ratio
 1.19- 0.53 0.02 -0.93
Financial Leverage Ratio
 -12.53- 5.51 1.83 -1.46
Debt Service Coverage Ratio
 -0.87- -0.60 1.87 -1.12
Interest Coverage Ratio
 -3.27- -1.66 3.23 -2.57
Debt to Market Cap
 0.38- 0.25 0.22 0.51
Interest Debt Per Share
 8.16- 5.39 4.19 10.61
Net Debt to EBITDA
 -1.78 -2.34 -0.02 -0.09 -0.92
Profitability Margins
Gross Profit Margin
18.74%-58.69%96.87%51.93%
EBIT Margin
-47.07%--55.05%73.62%-674.79%
EBITDA Margin
-39.70%--40.62%76.56%-625.97%
Operating Profit Margin
-48.99%--85.34%66.57%-695.52%
Pretax Profit Margin
-63.55%--106.51%53.01%-944.95%
Net Profit Margin
-63.79%--107.30%52.97%-951.10%
Continuous Operations Profit Margin
-63.79%--107.30%52.97%-951.10%
Net Income Per EBT
100.38%-100.75%99.93%100.65%
EBT Per EBIT
129.71%-124.80%79.63%135.86%
Return on Assets (ROA)
-50.12%-33.25%-27.53%49.97%-111.53%
Return on Equity (ROE)
-521.53%416.69%-151.54%91.39%162.70%
Return on Capital Employed (ROCE)
-69.92%-44.02%-31.39%105.40%-363.16%
Return on Invested Capital (ROIC)
-57.85%-34.49%-29.32%79.23%-140.24%
Return on Tangible Assets
-101.89%-58.51%-50.24%153.61%-1572.48%
Earnings Yield
-28.40%-30.02%-26.70%52.79%-84.53%
Efficiency Ratios
Receivables Turnover
 2.96- 2.82 235.03 6.85
Payables Turnover
 3.48- 1.68 0.91 0.92
Inventory Turnover
 2.52- 0.89 1.79 33.26
Fixed Asset Turnover
 38.40- 15.21 177.69 7.41
Asset Turnover
 0.52- 0.26 0.94 0.12
Working Capital Turnover Ratio
 8.09- 3.91 -3.69 -0.27
Cash Conversion Cycle
 96.84 188.81 324.65 -195.33 -331.53
Days of Sales Outstanding
 83.39 123.13 129.56 1.55 53.29
Days of Inventory Outstanding
 220.30 144.72 411.83 204.33 10.97
Days of Payables Outstanding
 206.85 79.05 216.73 401.22 395.79
Operating Cycle
 303.69 267.85 541.39 205.89 64.26
Cash Flow Ratios
Operating Cash Flow Per Share
 -2.60- -3.12 4.47 -4.90
Free Cash Flow Per Share
 -2.60- -3.14 2.22 -5.55
CapEx Per Share
 <0.01- 0.01 2.24 0.65
Free Cash Flow to Operating Cash Flow
 1.00- 1.00 0.50 1.13
Dividend Paid and CapEx Coverage Ratio
 -668.52- -235.28 1.99 -7.54
Capital Expenditure Coverage Ratio
 -668.52- -235.28 1.99 -7.54
Operating Cash Flow Coverage Ratio
 -0.36- -0.86 2.05 -0.67
Operating Cash Flow to Sales Ratio
 -0.45- -0.91 0.46 -3.99
Free Cash Flow Yield
-15.93%-21.23%-22.70%22.67%-40.20%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -4.91- -3.75 1.89 -1.18
Price-to-Sales (P/S) Ratio
 3.33- 4.02 1.00 11.25
Price-to-Book (P/B) Ratio
 -20.47- 5.68 1.73 -1.92
Price-to-Free Cash Flow (P/FCF) Ratio
 -7.38- -4.41 4.41 -2.49
Price-to-Operating Cash Flow Ratio
 -6.96- -4.42 2.20 -2.82
Price-to-Earnings Growth (PEG) Ratio
 0.16- 0.02 -0.01 0.04
Price-to-Fair Value
 -20.47- 5.68 1.73 -1.92
Enterprise Value Multiple
 -10.84- -9.91 1.22 -2.72
Enterprise Value
 314.72M 239.31M 157.45M 96.43M 127.16M
EV to EBITDA
 -9.68 -7.45 -9.91 1.22 -2.72
EV to Sales
 6.42 3.10 4.03 0.93 17.02
EV to Free Cash Flow
 -7.69 -6.87 -4.41 4.10 -3.76
EV to Operating Cash Flow
 -7.71 -6.88 -4.43 2.04 -4.26
Tangible Book Value Per Share
 -5.66- -3.63 -1.33 -16.89
Shareholders’ Equity Per Share
 -0.88- 2.43 5.67 -7.17
Tax and Other Ratios
Effective Tax Rate
 >-0.01- >-0.01 <0.01 >-0.01
Revenue Per Share
 5.76- 3.44 9.78 1.23
Net Income Per Share
 -3.68- -3.69 5.18 -11.67
Tax Burden
 1.00 1.00 1.01 1.00 1.01
Interest Burden
 1.71 1.30 1.93 0.72 1.40
Research & Development to Revenue
 0.50 0.29 0.68 0.18 4.09
SG&A to Revenue
 0.66 0.39 0.76 0.20 1.95
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.06 0.73
Income Quality
 0.62 0.71 0.85 0.86 0.42
Currency in CHF